Tao Shi

1.7k total citations
39 papers, 1.2k citations indexed

About

Tao Shi is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Tao Shi has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Immunology and 8 papers in Surgery. Recurrent topics in Tao Shi's work include Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). Tao Shi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). Tao Shi collaborates with scholars based in China, United States and Italy. Tao Shi's co-authors include Jia Wei, Xueru Song, Fangcen Liu, Shengxiang Ren, Caicun Zhou, Yuanlin Song, Tao Jiang, Henghui Zhang, Jie Hu and Baorui Liu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Tao Shi

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Shi China 16 548 490 419 170 170 39 1.2k
Angela Vasaturo Netherlands 19 899 1.6× 629 1.3× 393 0.9× 243 1.4× 203 1.2× 26 1.7k
Bo Zhu China 19 522 1.0× 423 0.9× 398 0.9× 197 1.2× 167 1.0× 50 1.1k
Kwun Wah Wen United States 14 700 1.3× 434 0.9× 460 1.1× 141 0.8× 69 0.4× 47 1.5k
Christof C. Smith United States 15 813 1.5× 713 1.5× 633 1.5× 181 1.1× 248 1.5× 26 1.5k
Tala Shekarian Switzerland 11 675 1.2× 694 1.4× 341 0.8× 154 0.9× 166 1.0× 15 1.3k
Magnus T. Dillon United Kingdom 15 700 1.3× 408 0.8× 534 1.3× 271 1.6× 132 0.8× 23 1.3k
Shailendra K. Gautam United States 18 469 0.9× 334 0.7× 543 1.3× 130 0.8× 114 0.7× 30 1.1k
Anna Wilkins United Kingdom 16 640 1.2× 430 0.9× 340 0.8× 400 2.4× 167 1.0× 39 1.3k
Sofia Farkona Canada 8 517 0.9× 444 0.9× 284 0.7× 119 0.7× 151 0.9× 13 983
Kristian M. Hargadon United States 13 913 1.7× 730 1.5× 382 0.9× 185 1.1× 121 0.7× 28 1.4k

Countries citing papers authored by Tao Shi

Since Specialization
Citations

This map shows the geographic impact of Tao Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Shi more than expected).

Fields of papers citing papers by Tao Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Shi. The network helps show where Tao Shi may publish in the future.

Co-authorship network of co-authors of Tao Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Shi. A scholar is included among the top collaborators of Tao Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Shi. Tao Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Tao, Qianqian Xu, Qingjun Huang, et al.. (2025). Design and Evolution of a Phosphorescent Protein via the Proximal Encoding of Lanthanide and the Antenna Chromophore. Journal of the American Chemical Society. 147(18). 15205–15215. 4 indexed citations
2.
Shi, Tao, et al.. (2024). Abstract 5285: DKK1 blockade inhibits progression of bone metastases via multiple mechanisms and synergize with zoledronate treatment. Cancer Research. 84(6_Supplement). 5285–5285. 1 indexed citations
3.
Luo, Yuting, Xueru Song, Zhe Yang, et al.. (2024). Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer. EMBO Molecular Medicine. 16(2). 251–266. 15 indexed citations
4.
Zhang, Xin, Tao Shi, Yanlong Zhang, et al.. (2024). Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy. BMC Cancer. 24(1). 445–445. 12 indexed citations
5.
Yang, Yi, Tao Shi, Xueru Song, et al.. (2024). Glycoengineering-based anti-PD-1-iRGD peptide conjugate boosts antitumor efficacy through T cell engagement. Cell Reports Medicine. 5(6). 101590–101590. 5 indexed citations
6.
Zhou, Xiaoyu, Xin Zhang, Hui Xu, et al.. (2023). Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer. Cancer Science. 114(7). 2798–2809. 18 indexed citations
7.
Shi, Tao, Xueru Song, Yuting Luo, et al.. (2022). DKK1 Promotes Tumor Immune Evasion and Impedes Anti–PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer. Cancer Immunology Research. 10(12). 1506–1524. 65 indexed citations
8.
Wang, Shuo, Xiaoxue Lai, Yanzhi Song, et al.. (2021). Sialic Acid Conjugate–Modified Liposomal Dexamethasone Palmitate Targeting Neutrophils for Rheumatoid Arthritis Therapy: Influence of Particle Size. AAPS PharmSciTech. 22(1). 16–16. 15 indexed citations
9.
Wang, Yue, Tao Shi, Xuan Wang, et al.. (2021). FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma. Journal of Translational Medicine. 19(1). 401–401. 8 indexed citations
10.
Song, Xueru, Yan Shi, Tao Shi, et al.. (2020). The efficacy of treating patients with non-metastatic gastric linitis plastica using surgery with chemotherapy and/or radiotherapy. Annals of Translational Medicine. 8(21). 1433–1433. 2 indexed citations
11.
Xu, Bo, Fangcen Liu, Qin Liu, et al.. (2020). Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC). Journal of Gastrointestinal Oncology. 11(6). 1431–1439. 33 indexed citations
13.
Jiang, Tao, Tao Shi, Henghui Zhang, et al.. (2019). Tumor neoantigens: from basic research to clinical applications. Journal of Hematology & Oncology. 12(1). 277 indexed citations
14.
Shi, Tao, Xueru Song, Yang Yang, et al.. (2019). Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based study. Cancer Medicine. 8(13). 6010–6020. 13 indexed citations
15.
Shi, Tao, Renwang Liu, Dian Ren, et al.. (2018). Clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients. Journal of Thoracic Disease. 10(2). E125–E129. 4 indexed citations
16.
Chen, Fei, Tao Shi, Yang Li, et al.. (2018). Multiple parameters for evaluating posterior longitudinal ligaments in thoracolumbar burst fractures. Der Orthopäde. 48(5). 420–425. 1 indexed citations
17.
Shi, Tao, et al.. (2017). A Terminal Rectal Mass Ultimately Identified by Histopathology Examination. Clinical Gastroenterology and Hepatology. 16(4). A23–A24. 1 indexed citations
18.
Long, Anhua, et al.. (2016). Analysis of the independent risk factors of neurologic deficit after thoracolumbar burst fracture. Journal of Orthopaedic Surgery and Research. 11(1). 128–128. 17 indexed citations
19.
Ye, Peng, Licheng Zhang, Tao Shi, et al.. (2015). Relationship between fracture-relevant parameters of thoracolumbar burst fractures and the reduction of intra-canal fracture fragment. Journal of Orthopaedic Surgery and Research. 10(1). 131–131. 11 indexed citations
20.
Huang, Qing, Xin Ma, Xu Zhang, et al.. (2013). Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4. PLoS ONE. 8(6). e67294–e67294. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026